Logo image of RGS

REGIS CORP (RGS) Stock Fundamental Analysis

NASDAQ:RGS - Nasdaq - US7589322061 - Common Stock - Currency: USD

21.61  -0.76 (-3.4%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to RGS. RGS was compared to 71 industry peers in the Diversified Consumer Services industry. RGS has a medium profitability rating, but doesn't score so well on its financial health evaluation. RGS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year RGS was profitable.
RGS had a positive operating cash flow in the past year.
RGS had negative earnings in 4 of the past 5 years.
In the past 5 years RGS always reported negative operating cash flow.
RGS Yearly Net Income VS EBIT VS OCF VS FCFRGS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of 18.05%, RGS belongs to the top of the industry, outperforming 92.19% of the companies in the same industry.
Looking at the Return On Equity, with a value of 143.38%, RGS belongs to the top of the industry, outperforming 98.44% of the companies in the same industry.
RGS has a Return On Invested Capital (3.23%) which is in line with its industry peers.
Industry RankSector Rank
ROA 18.05%
ROE 143.38%
ROIC 3.23%
ROA(3y)1.6%
ROA(5y)-3.87%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RGS Yearly ROA, ROE, ROICRGS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

RGS has a better Profit Margin (50.00%) than 100.00% of its industry peers.
The Operating Margin of RGS (9.04%) is better than 64.06% of its industry peers.
RGS's Operating Margin has improved in the last couple of years.
RGS's Gross Margin of 105.86% is amongst the best of the industry. RGS outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of RGS has grown nicely.
Industry RankSector Rank
OM 9.04%
PM (TTM) 50%
GM 105.86%
OM growth 3YN/A
OM growth 5Y92.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.74%
GM growth 5Y16.96%
RGS Yearly Profit, Operating, Gross MarginsRGS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so RGS is destroying value.
Compared to 1 year ago, RGS has about the same amount of shares outstanding.
RGS has less shares outstanding than it did 5 years ago.
The debt/assets ratio for RGS has been reduced compared to a year ago.
RGS Yearly Shares OutstandingRGS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
RGS Yearly Total Debt VS Total AssetsRGS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 0.35, we must say that RGS is in the distress zone and has some risk of bankruptcy.
RGS has a Altman-Z score (0.35) which is in line with its industry peers.
RGS has a debt to FCF ratio of 21.86. This is a negative value and a sign of low solvency as RGS would need 21.86 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 21.86, RGS is in line with its industry, outperforming 54.69% of the companies in the same industry.
A Debt/Equity ratio of 1.67 is on the high side and indicates that RGS has dependencies on debt financing.
The Debt to Equity ratio of RGS (1.67) is worse than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.67
Debt/FCF 21.86
Altman-Z 0.35
ROIC/WACC0.26
WACC12.21%
RGS Yearly LT Debt VS Equity VS FCFRGS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.40 indicates that RGS may have some problems paying its short term obligations.
RGS has a worse Current ratio (0.40) than 92.19% of its industry peers.
A Quick Ratio of 0.40 indicates that RGS may have some problems paying its short term obligations.
RGS has a Quick ratio of 0.40. This is amonst the worse of the industry: RGS underperforms 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.4
Quick Ratio 0.4
RGS Yearly Current Assets VS Current LiabilitesRGS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 2164.47% over the past year.
The Earnings Per Share has been growing by 100.49% on average over the past years. This is a very strong growth
RGS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.38%.
Measured over the past years, RGS shows a very negative growth in Revenue. The Revenue has been decreasing by -28.27% on average per year.
EPS 1Y (TTM)2164.47%
EPS 3YN/A
EPS 5Y100.49%
EPS Q2Q%542.86%
Revenue 1Y (TTM)-11.38%
Revenue growth 3Y-21%
Revenue growth 5Y-28.27%
Sales Q2Q%-8.49%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-107.14%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.39%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RGS Yearly Revenue VS EstimatesRGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
RGS Yearly EPS VS EstimatesRGS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 0.58, the valuation of RGS can be described as very cheap.
100.00% of the companies in the same industry are more expensive than RGS, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of RGS to the average of the S&P500 Index (29.62), we can say RGS is valued rather cheaply.
RGS is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 0.58
Fwd PE N/A
RGS Price Earnings VS Forward Price EarningsRGS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RGS indicates a rather cheap valuation: RGS is cheaper than 82.81% of the companies listed in the same industry.
92.19% of the companies in the same industry are more expensive than RGS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.66
EV/EBITDA 7.33
RGS Per share dataRGS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 60 80

4.3 Compensation for Growth

The decent profitability rating of RGS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.01
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for RGS!.
Industry RankSector Rank
Dividend Yield N/A

REGIS CORP

NASDAQ:RGS (2/21/2025, 8:00:01 PM)

21.61

-0.76 (-3.4%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)01-29 2025-01-29
Earnings (Next)04-29 2025-04-29
Inst Owners32.98%
Inst Owner Change-23.52%
Ins Owners10.8%
Ins Owner Change0.92%
Market Cap49.27M
Analysts80
Price TargetN/A
Short Float %2.26%
Short Ratio1.6
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.12
Dividend Growth(5Y)-5.43%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 0.58
Fwd PE N/A
P/S 0.26
P/FCF 9.66
P/OCF 8.8
P/B 0.74
P/tB N/A
EV/EBITDA 7.33
EPS(TTM)37.35
EY172.84%
EPS(NY)-2.67
Fwd EYN/A
FCF(TTM)2.24
FCFY10.36%
OCF(TTM)2.46
OCFY11.36%
SpS83.92
BVpS29.26
TBVpS-54.63
PEG (NY)N/A
PEG (5Y)0.01
Profitability
Industry RankSector Rank
ROA 18.05%
ROE 143.38%
ROCE 4.09%
ROIC 3.23%
ROICexc 3.31%
ROICexgc 6.18%
OM 9.04%
PM (TTM) 50%
GM 105.86%
FCFM 2.67%
ROA(3y)1.6%
ROA(5y)-3.87%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y22.11%
ROICexc growth 3YN/A
ROICexc growth 5Y42.42%
OM growth 3YN/A
OM growth 5Y92.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.74%
GM growth 5Y16.96%
F-Score6
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 1.67
Debt/FCF 21.86
Debt/EBITDA 5.43
Cap/Depr 15.29%
Cap/Sales 0.26%
Interest Coverage 250
Cash Conversion 27.26%
Profit Quality 5.33%
Current Ratio 0.4
Quick Ratio 0.4
Altman-Z 0.35
F-Score6
WACC12.21%
ROIC/WACC0.26
Cap/Depr(3y)33.16%
Cap/Depr(5y)56.96%
Cap/Sales(3y)0.77%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2164.47%
EPS 3YN/A
EPS 5Y100.49%
EPS Q2Q%542.86%
EPS Next Y-107.14%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.38%
Revenue growth 3Y-21%
Revenue growth 5Y-28.27%
Sales Q2Q%-8.49%
Revenue Next Year-6.39%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4.29%
EBIT growth 3YN/A
EBIT growth 5Y38.21%
EBIT Next Year66.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y121.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y126.38%
OCF growth 3YN/A
OCF growth 5YN/A